---
title: Apoptosis
description: Apoptosis (programmed cell death) is a highly regulated mechanism
  for removing damaged, infected, redundant, or potentially cancerous cells without
  inducing inflammation.
created: 2026-05-29
updated: 2026-09-02
tags:
  - biological-process
  - apoptosis
aliases: []
---

# Apoptosis
**Apoptosis** (programmed cell death) is a highly regulated mechanism for removing damaged, infected, redundant, or potentially cancerous cells without inducing inflammation.
## Mechanism and Triggers
- **Mitochondrial Pathway:** High levels of [[Reactive Oxygen Species]] (ROS) can damage [[Mitochondria]], leading to the release of **Cytochrome c**. This activates the caspase cascade (e.g., [[Caspase-3]]), leading to cell death.
- **DNA Damage Response:** Severe [[DNA Damage]] activates [[p53]], which can trigger apoptosis as a fail-safe mechanism.
- **Cross-talk:** Apoptosis often exhibits cross-talk with [[Autophagy]] to determine cell fate under stress.
## Role in [[Aging]] and Epigenetics
- **The Epigenetic-Apoptosis Axis:** [[Epigenetics]] serves as a regulatory layer determining cell survival. Hypermethylation of pro-apoptotic genes (like *FAS*, *BAX*, or *TP53*) can prevent the clearance of damaged cells, increasing [[Cancer]] risk.
- **[[Sirtuins]]s:** Sirtuins like [[SIRT1]] and [[SIRT6]] (dependent on NAD+) modulate p53 to balance survival and apoptosis.
- **Apoptosis Resistance:** During aging, some damaged cells become resistant to apoptosis and enter [[Senescence]], secreting pro-inflammatory cytokines ([[SASP|Senescence-Associated Secretory Phenotype]]) that drive **Inflammaging**.
- **Neurodegeneration:** Excessive apoptosis in post-mitotic tissues leads to neuron loss in [[Alzheimer's Disease]] and [[Parkinson's Disease]].
## Role in Cancer Research
- **Markers:** Common markers include [[Caspase-3|cleaved caspase-3]] and [[Annexin V]] binding.
- **Therapeutic Induction:** 
    - Evasion of apoptosis is a hallmark of cancer.
    - Prooxidant therapies (e.g., [[Ionizing Radiation]], high-dose [[Ascorbic Acid]]) aim to induce apoptosis in tumor cells.
    - [[melittin]] and [[Honeybee venom]] induce apoptosis in various cancer cell lines.
    - [[Ivermectin]] induces apoptosis via the mitochondrial pathway by upregulating [[Bax]] and downregulating [[Bcl-2]].
## Role in [[Cellular Reprogramming]]
- Apoptosis serves as a barrier to reprogramming efficiency. The stress of viral transduction and over-expression of factors like [[c-Myc]] triggers [[p53]]-mediated apoptosis.
- High rates of apoptosis among transduced cells significantly lower the efficiency of generating [[Induced Pluripotent Stem Cells]].
## Post-Translational Regulation of Apoptotic Effectors

> [!important] Five Critical Phosphorylation Switches
> The apoptotic network is regulated by multiple phosphorylation/dephosphorylation switches that determine cell fate:
> - **[[Caspase-8]]**: Phosphorylated by [[Src]] at Tyr380 (blocks apoptosis, promotes migration); dephosphorylated by [[SHP1]] (restores apoptotic sensitivity)
> - **[[Caspase-7]]**: Phosphorylated and inhibited by [[PAK2]] at Ser30/Thr173/Ser239 (drives chemoresistance in breast cancer)
> - **[[BAX]]**: Phosphorylated by [[ERK2]] at Thr167 and bound by [[Pin1]] (pro-survival); or by [[JNK]]/[[p38 MAPK]] at same site (pro-apoptosis)
> - **[[BAK]]**: Maintained inactive by Tyr108 phosphorylation; dephosphorylated by [[PTPN5]] to "license" activation
> - **[[XIAP]]**: Degraded via [[TBK1]]/[[IKKepsilon]] phosphorylation at Ser430 (pro-apoptosis); stabilized by [[Akt]] phosphorylation at Ser87 (pro-survival)

## Sex Differences in Cell Death

> [!important] Females die by apoptosis; males die by necrosis
> This is arguably the most fundamental sex difference in the vault. Under stress, cells from females preferentially undergo **caspase-dependent apoptosis** (controlled, non-inflammatory), while cells from males preferentially undergo **PARP-1/AIF-dependent necrosis** (uncontrolled, proinflammatory). This divergence is **cell-autonomous** (persists in hormone-free media and prepubertal animals) and has massive implications for stroke, myocardial infarction, neurodegeneration, and cancer therapy. See also [[p53]] for sex-specific regulation of the senescence-vs-apoptosis decision.

### The XX/XY Death-Pathway Divergence

| Feature | Females (XX) | Males (XY) | Citation |
|---------|-------------|------------|----------|
| **Primary death mode** | Caspase-dependent apoptosis | PARP-1/AIF-dependent necrosis | Liu et al., *Stroke* 2009; McCullough et al., *J Cereb Blood Flow Metab* 2005 |
| **Caspase-3 activation** | Higher after ischemia; pan-caspase inhibitor protects females only | Lower after ischemia | Liu et al., *Stroke* 2009 |
| **Caspase-8 activation** | Markedly greater; nuclear translocation XX-predominant (both sexes increase, female-predominant per Liu) | Lower; weak/absent nuclear translocation | Sharma et al., *ASN Neuro* 2011; Liu et al., *Stroke* 2009 |
| **Cytochrome C release** | Earlier; more robust (exact timings need primary page check) | Delayed | Sharma et al., *ASN Neuro* 2011 |
| **AIF translocation** | Delayed/minimal | Earlier; robust (by ~1 hr in Sharma) | Sharma et al., *ASN Neuro* 2011 |
| **Bcl-2 expression** | Higher with E2 support (OVX+E2 vs OVX-oil design) | Lower (adult cardiac context) | Dubal et al., *J Neurosci* 1999 (PMID 10414967) |
| **PARP-1 inhibition** | Exacerbates injury (PARP-1 is protective in females) | Protective (reduces infarct) | McCullough et al., 2005 |
| **Post-MI apoptosis** | 2.6% apoptotic index | 25.9% (10× higher) | Biondi-Zoccai/Abbate et al., *Heart* 2005 |

### Mechanism

- **XX neurons**: Mitochondrial cytochrome C → apoptosome → [[Caspase-9]] → [[Caspase-3]]; [[Caspase-8]] also activated and translocates to nucleus to cleave PARP-2.
- **XY neurons**: [[PARP-1]] overactivation → [[NAD+]] depletion → energy failure → AIF release from mitochondria → nuclear translocation → large-scale (50-kbp) DNA fragmentation (caspase-independent).
- **Bax KO reduces overall-number sex differences** in BNSTp/AVPV (Forger et al., *PNAS* 2004; TH+ AVPV exception remains). **[[Bcl-2]] overexpression reduces** sex differences (Zup et al., *J Neurosci* 2003).

### Estrogen–[[Bcl-2]] Neuroprotection

- Estrogen upregulates [[Bcl-2]] via ERα/β transcriptional activation: E2 prevents injury-induced bcl-2 downregulation in OVX females (Dubal et al., *J Neurosci* 1999, PMID 10414967). Intact female-vs-male % removed — Dubal compared OVX+E2 vs OVX-oil females.
- Estrogen upregulates anti-apoptotic Bcl-w and downregulates pro-apoptotic [[Bim]] in [[Alzheimer's Disease]] context (Patterson et al., *J Neurosci* 2007).

### Therapeutic Implications

> **[[Caspase]] inhibitors may preferentially protect females; [[PARP-1]]/AIF inhibitors may preferentially protect males.** This has been confirmed experimentally in stroke models: the pan-caspase inhibitor Q-VD-OPh reduced infarct volume only in females, while PARP-1 knockout protected males but exacerbated injury in females.

### References (sex differences in cell death)

**Core paradigm — XX apoptosis vs XY PARP-1/AIF necrosis**

- **McCullough LD, Zeng Z, Blizzard KK, Debchoudhury I, Hurn PD.** Ischemic nitric oxide and poly(ADP-ribose) polymerase-1 in cerebral ischemia: male toxicity, female protection. *J Cereb Blood Flow Metab.* 2005;25(4):502–512. doi:[10.1038/sj.jcbfm.9600059](https://doi.org/10.1038/sj.jcbfm.9600059). PMID: [15689952](https://pubmed.ncbi.nlm.nih.gov/15689952/). — PARP-1 deletion/nNOS inhibition protects males, exacerbates injury in females; loss of PARP-1 reverses estradiol neuroprotection.
- **Yuan M, Siegel C, Zeng Z, Li J, Liu F, McCullough LD.** Sex differences in the response to activation of the poly(ADP-ribose) polymerase pathway after experimental stroke. *Exp Neurol.* 2009;217(1):210–218. doi:[10.1016/j.expneurol.2009.02.012](https://doi.org/10.1016/j.expneurol.2009.02.012). — PARP-1 pathway drives male necrotic death; confirms sex-specific divergence downstream of PARP-1.
- **Liu F, Li Z, Li J, Siegel C, Yuan R, McCullough LD.** Sex differences in caspase activation after experimentally induced cerebral ischemia. *Stroke.* 2009;40(5):1842–1848. doi:[10.1161/STROKEAHA.108.538686](https://doi.org/10.1161/STROKEAHA.108.538686). PMID: [19265047](https://pubmed.ncbi.nlm.nih.gov/19265047/). — Females show higher/earlier caspase activation after ischemia; pan-caspase inhibition protects females only.
- **McCullough LD, et al.** Sex differences in the response to PARP-1 deletion and caspase inhibition after stroke. *Stroke.* 2011;42(3):739–745. PMID: [21311064](https://pubmed.ncbi.nlm.nih.gov/21311064/); PMC[3066270](https://pmc.ncbi.nlm.nih.gov/articles/PMC3066270/). — Q-VD-OPh (pan-caspase) reduces infarct in females only and reverses the harm of PARP-1 deletion in females.
- **Sharma J, Nelluru G, Wilson MA, Johnston MV, Hossain MA.** Sex-specific activation of cell death signalling pathways in cerebellar granule neurons exposed to oxygen glucose deprivation followed by reoxygenation. *ASN Neuro.* 2011;3(2):85–97. doi:[10.1042/AN20100032](https://doi.org/10.1042/AN20100032). PMID: [21382016](https://pubmed.ncbi.nlm.nih.gov/21382016/). — Cell-autonomous: XX neurons die via delayed caspase-8/3 (nuclear translocation of caspase-8 in XX only); XY neurons die via AIF–PARP-1-dependent pathway.

**Sex in the Bcl-2/Bax setpoint**

- **Dubal DB, Shughrue PJ, Wilson ME, Merchenthaler I, Wise PM.** Estradiol modulates bcl-2 in cerebral ischemia: a potential contribution to neuroprotection. *J Neurosci.* 1999;19(15):6385–6393. PMID: [10414967](https://pubmed.ncbi.nlm.nih.gov/10414967/). — E2 prevents injury-induced bcl-2 loss in OVX females (OVX+E2 vs OVX-oil design).
- **Forger NG, Rosen GJ, Waters EM, Jacob D, Simerly RB, de Vries GJ.** Deletion of Bax reduces overall-number sex differences in the mouse forebrain. *Proc Natl Acad Sci USA.* 2004;101(37):13666–13671. doi:[10.1073/pnas.0404644101](https://doi.org/10.1073/pnas.0404644101). PMID: [15342910](https://pubmed.ncbi.nlm.nih.gov/15342910/). — Bax KO reduces BNSTp/AVPV dimorphism (TH+ AVPV exception remains).
- **Zup SL, Carrier H, Waters EM, Tabor A, Bengston L, Rosen GJ, Simerly RB, Forger NG.** Overexpression of Bcl-2 reduces sex differences in neuron number in the brain and spinal cord. *J Neurosci.* 2003;23(6):2357–2362. doi:[10.1523/JNEUROSCI.23-06-02357.2003](https://doi.org/10.1523/JNEUROSCI.23-06-02357.2003). — Bcl-2 overexpression reduces (not eliminates) sex differences.

**Clinical (human) evidence**

- **Biondi-Zoccai GG, Abbate A, Bussani R, Camilot D, De Giorgio F, Marino M-P, Silvestri F, Baldi F, Biasucci LM, Baldi A.** Reduced post-infarction myocardial apoptosis in women: a clue to their different clinical course? *Heart.* 2005;91(1):99–101. doi:[10.1136/hrt.2003.018754](https://doi.org/10.1136/hrt.2003.018754). — Human autopsy: peri-infarct apoptotic index ~10× higher in men (25.9%) than women (2.6%), with higher cardiac Bax expression in men. *(Note: first author is Biondi-Zoccai; Abbate is a co-author.)*

**Broader synthesis**

- **Li H, Pin S, Zeng Z, Wang MM, Andreasson KA, McCullough LD.** Sex differences in cell death. *Ann Neurol.* 2005;58(2):317–321. — Early formal statement of the XX-caspase / XY-PARP-1-AIF paradigm.
- **Tang et al.** Sex differences during ischemic stroke. *Front Mol Neurosci.* 2022;15:860959. — Modern review synthesizing cell-death and neurovascular-unit dimorphism.
- **Shen H, Holliday M, Sheikh-Hamad D, et al.** Sirtuin-3 mediates sex differences in kidney ischemia-reperfusion injury. *Transl Res.* 2021;235:15–31. — Same XX-apoptotic / XY-necrotic pattern beyond brain (see also [[SIRT3]]).

## Related Entities
- **Proteins:** [[p53]], [[Caspase-3]], [[Caspase-7]], [[Caspase-8]], [[Caspase-9]], [[Bax]], [[Bcl-2]], [[BAK]], [[XIAP]], [[SIRT1]], [[Beclin1]]
- **Regulators:** [[SHP1]], [[PAK2]], [[Pin1]], [[PTPN5]], [[TBK1]], [[Src]], [[FAK]]
- **Molecules:** [[Reactive Oxygen Species]], [[Cytochrome c]], [[Ascorbic Acid]], [[melittin]], [[Ivermectin]], [[TRAIL]], [[FasL]]
- **Processes:** [[Autophagy]], [[Senescence]], [[DNA Damage]], [[Epigenetics]], [[Inflammation]]

#

# 

## Documents

List of documents that mention this entity

  - [[_document_ - Autophagy and intermittent fasting the connection for cancer therapy?|Autophagy and intermittent fasting the connection for cancer therapy?]]
    - REVIEW ARTICLE Under a Creative Commons license Open access KEYWORDS Apoptosis Macroautophagy Intermittent Fasting Cancer Therapy Autophagy: definiti

  - [[_document_ - Autophagy takes it all – autophagy inducers target immune aging|Autophagy takes it all – autophagy inducers target immune aging]]
    - It is also known that senescent cells shut down division but do not undergo Apoptosis and, in this way, prevent the development of cancer (Serrano et al., 1997). On the one hand, the chronic presence of senescent cells is harmful to surround

  - [[_document_ - TFEB AND TFE3, LINKING LYSOSOMES TO CELLULAR ADAPTATION TO STRESS|TFEB AND TFE3, LINKING LYSOSOMES TO CELLULAR ADAPTATION TO STRESS]]
    - TFE3 targets included not only autophagic/lysosomal genes, but also ATF4, an essential master regulator of the integrated stress response, and genes implicated in cell response to stress, signaling, and Apoptosis (Martina et al 2016).

  - [[_document_ - The Beneficial and Adverse Effects of Autophagic Response to Caloric Restriction and Fasting|The Beneficial and Adverse Effects of Autophagic Response to Caloric Restriction and Fasting]]
    - Despite the protective role of autophagy on injured cells, abnormal or excessive autophagic responses cause several pathological outcomes via the stimulation of programmed cell death such as Apoptosis, Pyroptosis, etc. \[, , , \].

  - [[_document_ - mTOR signaling at a glance|mTOR signaling at a glance]]
    - Inhibition of Akt following mTORC2 depletion reduces the phosphorylation of, and therefore activates, the FoxO1 (FoxO1) and FOXO3a transcription factors, which control the expression of genes involved in stress resistance, metabolism, cell-cycle arrest and ...

  - [[_document_ - Apoptosis in cancer from pathogenesis to treatment|Apoptosis in cancer from pathogenesis to treatment]]
    - Rebecca SY Wong 1,✉ PMCID: Abstract Apoptosis is an ordered and orchestrated cellular process that occurs in physiological and pathological conditions. It is also one of the most studied topics among cell biologists.

  - [[_document_ - Caspase|Caspase]]
    - Caspase Caspases (Cysteine-aspartic proteases) are a family of protease enzymes playing essential roles in programmed cell death (Apoptosis), necrosis, and inflammation.

  - [[_document_ - Evading apoptosis in cancer|Evading apoptosis in cancer]]
    - Here we discuss emerging evidence indicating how cancer cells adopt various strategies to override apoptosis including amplifying the anti-apoptotic machinery, downregulating the pro-apoptotic program, or both.

  - [[_document_ - Honeybee venom and melittin suppress growth factor receptor activation in HER2-enriched and triple-negative breast cancer - npj Precision Oncology|Honeybee venom and melittin suppress growth factor receptor activation in HER2-enriched and triple-negative breast cancer - npj Precision Oncology]]
    - Honeybee venom and melittin also induced Apoptosis in MCF7 cells , and reduced cell viability and migration in MDA-MB-231 breast cancer cells .

  - [[_document_ - Ivermectin, a potential anticancer drug derived from an antiparasitic drug|Ivermectin, a potential anticancer drug derived from an antiparasitic drug]]
    - On the other hand, ivermectin promotes programmed cancer cell death, including Apoptosis, Autophagy and Pyroptosis. Ivermectin induces apoptosis and autophagy is mutually regulated.

  - [[_document_ - Oral Fenbendazole for Cancer Therapy in Humans and Animals 1|Oral Fenbendazole for Cancer Therapy in Humans and Animals]]
    - Mentioned in this document

  - [[_document_ - Cellular Mechanisms and Regulation of Quiescence|Cellular Mechanisms and Regulation of Quiescence]]
    - Gene regulation in quiescent cells also prevents Apoptosis and protects cells from accumulating damage over time (Coller et al., 2006; Min and Spencer, 2019). Accordingly, gen...

  - [[_document_ - Epigenetic alterations—The silent indicator for early aging and age‐associated health‐risks|Epigenetic alterations—The silent indicator for early aging and age‐associated health‐risks]]
    - Over the period of lifespan, cellular differentiation, proliferation, and maturation occur followed by Apoptosis and these synchronizations get out of balance with age.

  - [[_document_ - Molecular Insights into Reprogramming-Initiation Events Mediated by the OSKM Gene Regulatory Network|Molecular Insights into Reprogramming-Initiation Events Mediated by the OSKM Gene Regulatory Network]]
    - Experiments confirmed that upon viral transduction, the immediate response is Innate Immunity, which induces Reactive Oxygen Species, oxidative DNA Damage, p53 activation, Senescence, and Apoptosis, ultimately leading to a reduction in the Cellular Reprogra...

  - [[_document_ - Small molecule compounds that induce cellular senescence|Small molecule compounds that induce cellular senescence]]
    - Moreover, IR and UV Radiation, along with most of the DNA‐damaging agents presented in the table, induce Apoptosis rather than senescence when used at higher doses. These observations further emphasize the relationship between Apoptosis and senescence.

  - [[_document_ - Neuromelanin, one of the most overlooked molecules in modern medicine, is not a spectator|Neuromelanin, one of the most overlooked molecules in modern medicine, is not a spectator]]
    - Sequestration of MPP+ then appears to induce cellular Apoptosis leading to cell death and a downstream cascading immune response due to the release of previously unseen antigens (Sulzer et al., 2008).

  - [[_document_ - Oxidative Stress Harms and Benefits for Human Health|Oxidative Stress Harms and Benefits for Human Health]]
    - Processes, like protein phosphorylation, activation of several transcriptional factors, Apoptosis, Immunity, and Differentiation, are all dependent on a proper ROS production and presence inside cells that need to be kept at a low level \[\].

  - [[_document_ - The Sirtuin System The Holy Grail of Resveratrol?|The Sirtuin System The Holy Grail of Resveratrol?]]
    - In similar fashion, SIRT-7 deficient mice had myocardium defined by extensive fibrosis and high basal rates of Apoptosis, resulting in high levels of cardiomyopathy \[\].

  - [[_document_ - sirtuins (overview, CD38 KO risks, cancer therapies)|sirtuins (overview, CD38 KO risks, cancer therapies)]]
    - Myristoylation is involved in protein targeting to membranes and in Apoptosis pathways. Some sirtuins (e.g., SIRT6) show efficient demyristoylase activity.

  - [[_document_ - sirtuins Michan_S_Sinclair_D_Sirtuins_in_mammals_insights_i|sirtuins Michan_S_Sinclair_D_Sirtuins_in_mammals_insights_i]]
    - SIRT1-dependent deacetylation of p53 inhibits its transactivation activity and suppresses Apoptosis in response to Oxidative Stress and DNA Damage . Although the SIRT1/p53 pathway may promote a beneficial effect in different diseases, Chen et al.

  - [[_document_ - sirtuins Shedding light on structure, function and regulation of human sirtuins a comprehensive review|sirtuins Shedding light on structure, function and regulation of human sirtuins a comprehensive review]]
    - and in lung epithelial cells, Forkhead protein FOXO3a deacetylation inhibits Apoptosis induced by cigarette smoke extract (Wang et al. ).

  - [[_document_ - sirtuins in health and disease s41392-022-01257-8|sirtuins in health and disease s41392-022-01257-8]]
    - Notably, this protein family plays a variety of important roles in cellular biology such as inflammation, metabolism, oxidative stress, and Apoptosis, etc., thus, it is considered a potential therapeutic target for different kinds of pathologies including c...


## Connections
- [[Mitochondria]]: The central organelle and sensor for the intrinsic apoptotic pathway.
- [[Oxidative Stress]]: One of the most common physiological triggers for apoptosis.
- [[Senescence]]: An alternative fate to apoptosis for damaged cells.
- [[Cancer]]: Often arises when cells fail to undergo apoptosis.
- [[Caspases]] — executioner proteases that execute the mitochondrial/extrinsic death programs; the female-preferred death effectors in the sex-difference framework
- [[PARP1]] — the male-preferred death effector; XY cells die via PARP-1/AIF-dependent necrosis rather than caspases
- [[p53]] — sex-hormone-regulated switch between the senescence and apoptosis arms (E2↔p53 crosstalk; see Sex Differences)
- [[Bcl-2]] — estrogen-driven anti-apoptotic setpoint; the molecular basis of female apoptotic resistance

## Linking Summary (Sex Differences — Cell-Death Cross-Link, 2026-09-02)

- **Unified sex-difference cell-death framework** cross-referenced across [[Apoptosis]] ↔ [[Caspases]] ↔ [[p53]] ↔ [[Bcl-2]] and linked to the PARP-1/NAD⁺ axis via [[NAD+]].
- Cross-links added: [[Caspases]], [[PARP1]], [[p53]], [[Bcl-2]].
- Strong connections to strengthen: [[Apoptosis]] ↔ [[Caspases]] (XX-caspase arm), [[Apoptosis]] ↔ [[PARP1]] (XY-necrosis arm), [[Apoptosis]] ↔ [[p53]] (senescence-vs-apoptosis sex decision), [[Apoptosis]] ↔ [[Bcl-2]] (estrogen setpoint).

## Linking Summary
- New links added: [[Aging]], [[Alzheimer's Disease]], [[Annexin V]], [[Ascorbic Acid]], [[Autophagy]], [[Bax]], [[Bcl-2]], [[Beclin1]], [[Cancer]], [[Cellular Reprogramming]], [[Senescence]], [[Cytochrome c]], [[DNA Damage]], [[Epigenetics]], [[Honeybee venom]], [[Induced Pluripotent Stem Cells]], [[Inflammation]], [[Ionizing Radiation]], [[Ivermectin]], [[Mitochondria]], [[Neurodegenerative Diseases]], [[Parkinson's Disease]], [[Reactive Oxygen Species]], [[SASP|Senescence-Associated Secretory Phenotype]], [[SIRT1]], [[SIRT6]], [[Sirtuins]], [[Caspase-3]], [[melittin]], [[p53]], [[c-Myc]], [[MPP+]], [[Neuromelanin]].
- Suggested new entity notes to create: [[Cytochrome c]], [[Bax]], [[Bcl-2]], [[Annexin V]], [[Caspase-3]], [[Necrosis]], [[Caspases]].
  - Strong connections to strengthen: [[Apoptosis]] ↔ [[Mitochondria]], [[Apoptosis]] ↔ Cellular Senescence, [[Apoptosis]] ↔ [[p53]], [[Apoptosis]] ↔ [[Mitochondrial Dysfunction]].
